Involvement of a p53-dependent pathway in rubella virus-induced apoptosis

Virology

Volumn 259, Issue 1, 1999, Pages 74-84

  Megyeri, Klara ^a,b   Berencsi, Klara ^a   Halazonetis, Thanos D ^a   Prendergast, George C ^a   Gri, Giorgia ^a   Plotkin, Stanley A ^c   Rovera, Giovanni ^a   Gönczöl, Eva ^a,b  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c Pasteur Merieux Connaught   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE EXPRESSION; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; RUBELLA VIRUS; ULTRAVIOLET IRRADIATION; VERO CELL; VIRION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS STRAIN;

EID: 0033587324     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9757     Document Type: Article

References (73)

1. Allday M. J., Sinclair A., Parker G., Crawford D. H., Farrell P. J. Epstein-Barr virus efficiently immortalizes human B cells without neutralizing the function of p53. EMBO J. 14:1995;1382-1391.
2. Bellanti J. A., Artenstein M. S., Olson L. C., Buescher E. L., Luhrs C. E., Milstead K. L. Congenital rubella: Clinicopathologic, virologic and immunologic studies. Am. J. Dis. Child. 110:1965;464-472.
3. Bowden D. S., Pedersen J. S., Toh B. H., Westaway E. G. Distribution by immunofluorescence of viral products and actin-containing cytoskeletal filaments in rubella virus-infected cells. Arch. Virol. 92:1987;211-219.
4. Caelles C., Helmberg A., Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370:1994;220-223.
5. Chen W., Cooper N. R. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kB activity. J. Virol. 70:1996;4849-4853.
6. Chen W., Huang S., Cooper N. R. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: Apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation. Virology. 251:1998;217-226.
7. Chen X., Ko L. J., Jayaraman L., Prives C. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:1996;2438-2451.
8. Chirillo P., Pagano S., Natoli G., Puri P. L., Burgio V. L., Balsano C., Levrero M. The hepatitis B virus X gene induces p53-mediated programmed cell death. Proc. Natl. Acad. Sci. USA. 94:1997;8162-8167.
9. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
10. Desaintes C., Demeret C., Goyat S., Yaniv M., Thierry F. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. EMBO J. 16:1997;504-514.
11. Diaz-Guerra M., Rivas C., Esteban M. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells. Virology. 236:1997;354-363.
12. Driscoll S. G. Histopathology of gestational rubella. Am. J. Dis. Child. 118:1969;49-53.
13. Dudgeon J. A. Congenital rubella: Pathogenesis and immunology. Am. J. Dis. Child. 118:1969;35-44.
14. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
15. Gillet G., Brun G. Viral inhibition of apoptosis. Trends Microbiol. 4:1996;312-317.
16. WAF1/CIP1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
17. 2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol. 16:1996;6654-6660.
18. Gottlieb M. T., Oren M. p53 in growth control and neoplasia. Biochem. Biophys. Acta. 1287:1996;77-102.
19. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:1994;6264-6277.
20. Griffin D. E., Hardwick J. M. Regulators of apoptosis on the road to persistent alphavirus infection. Annu. Rev. Microbiol. 51:1997;565-592.
21. Hassel B. A., Zhou A., Sotomayor C., Maran A., Silverman R. H. A dominant negative mutant of 2-5A-dependent RNAse suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12:1993;3297-3304.
22. Haupt Y., Rowan S., Shaulian E., Voudsen K., Oren M. Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9:1995;2170-2183.
23. Hemphill M. L., Forng R.-Y., Abernathy E. S., Frey T. K. Time course of virus-specific macromolecular synthesis during rubella virus infection in Vero cells. Virology. 162:1988;65-75.
24. Hupp T. R., Sparks A., Lane D. P. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell. 83:1995;237-245.
25. Jansen-Dürr P. How viral oncogenes make the cell cycle. Trends Genet. 12:1996;270-276.
26. Jayaraman L., Prives C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell. 81:1995;1021-1029.
27. Joe A. K., Foo H. H., Kleeman L., Levine B. The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death. J. Virol. 72:1998;3935-3943.
28. Ko L. J., Prives C. p53: Puzzle and paradigm. Genes Dev. 10:1996;1054-1072.
29. Lee J. Y., Bowden D. S., Marshall J. A. Membrane junctions associated with rubella virus infected cells. J. Submicrosc. Cytol. Pathol. 28:1996;101-108.
30. Lee S. B., Rodríquez D., Rodríquez J. R., Esteban M. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology. 231:1997;81-88.
31. Levine B., Huang Q., Isaacs J. T., Reed J. C., Griffin D. E., Hardwick J. M. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature. 361:1993;739-742.
32. Levine B., Goldman J. E., Jiang H. H., Griffin D. E., Hardwick J. M. Bcl-2 protects mice against fatal alphavirus encephalitis. Proc. Natl. Acad. Sci. USA. 93:1996;4810-4815.
33. Lewis J., Wesselingh S. L., Griffin D. E., Hardwick J. M. Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J. Virol. 70:1996;1828-1835.
34. Lin K.-I., Lee S.-H., Narayanan R., Baraban J. M., Hardwick J. M., Ratan R. R. Thiol agents and bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131:1995;1149-1161.
35. Lin K.-I., DiDonato J. A., Hoffman A., Hardwick J. M., Ratan R. R. Suppression of steady-state, but not stimulus-induced NF-kappa B activity inhibits alphavirus-induced apoptosis. J. Cell Biol. 141:1998;1479-1487.
36. 1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:1996;934-947.
37. Lowe S. W., Ruley H. E. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:1993;535-545.
38. Malim M. H., Bohnlein S., Hauber J., Cullen B. R. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell. 58:1989;205-214.
39. Martinez J. D., Craven M. T., Joseloff E., Milczarek G., Bowden G. T. Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylation. Oncogene. 14:1997;2511-2520.
40. McCarthy K. Cell cultures useful for the study of rubella. Am. J. Dis. Child. 118:1969;78-83.
41. Miyashita T., Reed J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
42. Naeye R. L., Blanc W. Pathogenesis of congenital rubella. J. Am. Med. Assoc. 194:1965;1277-1283.
43. Nelson W. G., Kastan M. B. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1994;1815-1823.
44. Nusbacher J., Hirschhorn K., Cooper L. Z. Chromosomal abnormalities in congenital rubella. N. Eng. J. Med. 276:1967;1409-1413.
45. Okan I., Wang Y., Chen F., Hu L. F., Imreh S., Klein G., Wiman K. G. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene. 11:1995;1027-1031.
46. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
47. Ohnishi T., Wang X., Ohnishi K., Takahashi A. p53-dependent induction of WAF1 by cold shock in human glioblastoma cells. Oncogene. 16:1998;1507-1511.
48. Plotkin S. A. Rubella vaccine. Plotkin S. A., Mortimer E. A. Vaccines. 1994;303-336 Saunders, Philadelphia.
49. Plotkin S. A., Oski F. A., Hartnett E. M., Hervada A. R., Friedman S., Gowing F. Some recently recognized manifestations of the rubella syndrome. J. Pediatr. 67:1965a;182-191.
50. Plotkin S. A., Boue A., Boue J. G. The in vitro growth of rubella virus in human embryo cells. Am. J. Epidemiol. 81:1965b;71-85.
51. Plotkin S. A., Vaheri A. Human fibroblasts infected with rubella virus produce a growth inhibitor. Science. 156:1967;659-661.
52. Polyak K., Waldman T., He T.-C., Kinzler K. W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1996;1945-1952.
53. Pugachev K. V., Abernathy E. S., Frey T. K. Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: Determinants of cytopathogenicity induced by RUB map to the nonstructural proteins. J. Virol. 71:1997;562-568.
54. Pugachev K. V., Frey T. K. Rubella virus induces apoptosis in culture cells. Virology. 250:1998;359-370.
55. Rawls W. E., Melnick J. L. Rubella virus carrier cultures derived from congenitally infected infants. J. Exp. Med. 123:1966;795-816.
56. Razvi E. S., Welsh R. M. Apoptosis in viral infections. Adv. Virus Res. 45:1995;1-60.
57. Sabbatini P., Lin J., Levine A. J., White E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9:1995;2184-2192.
58. Sakamuro F., Sabbatini P., White E., Prendergast G. C. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene. 15:1997;887-898.
59. Sato H., Albrecht P., Ennis F. A. A novel plaque method for attenuated rubella virus in Vero cell cultures. Arch. Virol. 59:1979;281-284.
60. Shieh S. Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by Mdm2. Cell. 91:1997;325-334.
61. Singer D. B., Rudolph A. J., Rosenberg H. S., Rawls W. E., Boniuk M. Pathology of the congenital rubella syndrome. Pediatrics. 71:1967;665-675.
62. Strack P. R., Frey M. W., Rizzo C. J., Cordova B., George H. J., Meade R., Ho S. P., Corman J., Tritch R., Korant B. D. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. USA. 93:1996;9571-9576.
63. Su F., Schneider R. J. Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor α Proc. Natl. Acad. Sci. USA. 94:1997;8744-8749.
64. Subramanian T., Tarodi B., Chinnadurai G. p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: Suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ. 6:1995;131-137.
65. Subramanian T., Tarodi B., Govindarajan R., Boyd J. M., Yoshida K., Chinnadurai G. Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. Gene. 124:1993;173-181.
66. Takizawa T., Ohashi K., Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 70:1996;8128-8132.
67. Tondury G., Smith D. W. Fetal rubella pathology. J. Pediatr. 68:1966;867-879.
68. Xiong Y., Hannon G., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
69. Wada N., Matsumura M., Ohba Y., Kobayashi N., Takizawa T., Nakanishi Y. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J. Biol. Chem. 270:1995;18007-18012.
70. Waterman M. J. F., Waterman J. L. F., Halazonetis T. D. An engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants. Cancer Res. 56:1996;158-163.
71. Waterman M. J. F., Stavridi E. S., Waterman J. L. F., Halazonetis T. D. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genet. 19:1998;175-178.
72. Wolinsky J. S. Rubella. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;899-929 Lippincott-Raven, Philadelphia.
73. Yoneda T., Urade M., Sakuda M., Miyazaki T. Altered growth, differentiation, and responsiveness of epidermal growth factor of human embryonic mesenchymal cells of palate by persistent rubella virus infection. J. Clin. Invest. 77:1986;1613-1621.